Cellular Biomedicine Group Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Stock Rating
2
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
2
Upside
0.00%
Analysts
0
Price Target
$0.00
Cellular Biomedicine Group Stock Forecast and Price Target
The average target price for Cellular Biomedicine Group's stock set by renowned analysts in recent months is $0.00, representing a potential upside of approximately 100% from its last closing price if met by 2024. This estimation is based on a high estimate of $0.00 and a low estimate of $0.00.
$0.00
0.00% Upside
-